Search

In stock

Cabergoline Tablets IP 0.5 mg x 4tabs Cabger (imeta )



$11

Cabergoline Tablets IP 0.5 mg x 4tabs Cabger (imeta )

This drug can enhance sexual pleasure in men

Prolactin Inhibition: Whenever progestin-based compounds (trenbolone and nandrolone deca) are used, prolactin levels rise. Lowering prolactin levels with cabergoline can help keep prolactin-based gynecomastia at bay and keep your libido strong.

Usage amount

In general, for adults, take one tablet twice a week (every three days), or one tablet daily before bedtime if symptoms are severe.

 

The dosage may be increased or decreased depending on age and symptoms, but the upper limit for a single dose is 1.0 mg.

 

Product details

 

CABGO-SURE 0.50 (Cabergoline) 0.5 mg is a drug that suppresses prolactin secretion by stimulating dopamine receptors in the endocrine system, and is primarily used to improve the symptoms of hyperprolactin secretion, including galactorrhea, hyperprolactinemic ovulation disorder, hyperprolactinemic pituitary adenoma (only in cases that do not require surgical treatment), and postpartum lactation suppression.

 

Cabergoline, the active ingredient in CABGO-SURE 0.50 (Cabergoline), is a dopamine receptor agonist that acts directly on dopamine D2 receptors in the anterior pituitary gland to control prolactin secretion.

Due to this effect, it is said that blood prolactin levels fall within the normal range approximately three months after oral administration.

 

Cabergoline also acts on the dopamine D2 receptors in the substantia nigra and striatum of the central nervous system, and is therefore approved in Japan as a treatment for Parkinson’s disease.

 

Prolactin is a hormone secreted by men, and is known to rapidly reduce libido after ejaculatory orgasm. High prolactin levels are also known to decrease sexual desire.
Cabergoline, the active ingredient in CABGO-SURE 0.50 (Cabergoline), has been reported to significantly reduce prolactin levels, thereby increasing male sexual arousal and resulting in stronger ejaculations.

 

————————————————–

Scientists believe they are close to developing a pill to increase men’s stamina that would be as popular as Viagra.

The drug, which is used to treat Parkinson’s disease, has been found to increase the likelihood of sustaining multiple orgasms during sex.

In the study, the drug Cabergolin was prescribed to minimize the effects of the hormone prolactin, which is produced by men starting weeks after orgasm.

We interviewed these subjects and found that they were able to have multiple orgasms in very rapid succession.

The hormone has the effect of reducing a man’s desire for more sex by preventing new erections.

Typically, a study of 60 healthy men aged 22 to 31 required a 19-minute break after ejaculating before having sex again.

However, after taking cabergoline, I was able to have several orgasms within minutes.

Manfred Shedlowsky, a medical psychologist who was involved in the trial in Essen, Germany, said it boosts libido, allowing men to resume orgasm more quickly.

He said: “We thought that prolactin rises after orgasm and that perhaps prolactin might be a negative feedback system.

“Subjects taking this drug reported lower prolactin levels, better orgasms, and shorter refractory periods.

New Developments

“We interviewed these subjects and found that they were capable of having multiple orgasms in very rapid succession.

“This sits very well with the hypothesis that orgasm and sexual desire are controlled by prolactin and dopamine in the brain.”

Cabergoline has been on the market in Germany for several months and is used to treat Parkinson’s disease and for prophylaxis in milk-producing women if they wish to stop breastfeeding.

According to an article published in the International Journal of Impotence Research, the drug had no side effects for men in the trial.

The researchers are now planning trials to see if cabergoline has the same effect on women.

The market for drugs like Viagra is burgeoning and is thought to be worth around $1 billion.

Cabergoline is thought to have similar potential.

Back to Top
Product has been added to your cart